Publications by authors named "Eva Tomsova"

Claim this Profile
O
Once versus three times daily dosing of oral budesonide for active Crohn's disease: a double-blind, double-dummy, randomised trial.
Axel Dignass, Simeon Stoynov, Andrey E Dorofeyev, Galina A Grigorieva, Eva Tomsová

J Crohns Colitis· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease.
Andreas Tromm, Ivan Bunganič, Eva Tomsová, Zsolt Tulassay, Milan Lukáš

Gastroenterology· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis